# Titration Study of ABX-1431

> **NCT03447756** · PHASE1 · COMPLETED · sponsor: **Abide Therapeutics** · enrollment: 39 (actual)

## Conditions studied

- Post Herpetic Neuralgia
- Diabetic Peripheral Neuropathy
- Small Fiber Neuropathy
- Post-Traumatic Neuralgia

## Interventions

- **DRUG:** ABX-1431
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03447756
- **Lead sponsor:** Abide Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-02
- **Primary completion:** 2019-05-07
- **Final completion:** 2019-05-07
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2019-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03447756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03447756, "Titration Study of ABX-1431". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03447756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*